Vor Biopharma Inc. (VOR)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
VOR price, last 12 months
Key stats
- Previous close
- $17.83
- Open
- $17.91
- Day range
- $17.71 – $19.14
- 52-week range
- $6.50 – $26.00
- Volume
- 830.7K
- Avg volume (20 days)
- 725.1K
- Market cap
- $1.2B
Performance
Technicals and fundamentals
About Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $1.2B